Delivery Order SPE2DB24D3013-SPE2DB25FFJJE
Award Date
2/5/25
Potential Completion Date
2/6/25
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,752.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 29, 2023. This award is a part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $30,965.35, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, with a completion date of November 20, 2024. The contract was awarded on November 19, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, valued at $25,573.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of January 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,853.61 firm fixed-price delivery order is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award, valued at $15,154.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of December 19, 2024, is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a Set-Aside. Amerisourcebergen Drug Corp, the prime...
This federal contract award, valued at $9,475.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, with a completion date of November 13, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award, valued at $1,951.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a completion date of January 3, 2025. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,623.68, is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of September 10, 2024. The contract was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of REXULTI 2 MG TABLET 30S. The contract is a Delivery Order with a Firm Fixed Price of $6,395.07 and a completion date of September 13, 2024. This contract is not associated with any set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for supplying this pharmaceutical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,168.15, is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 1, 2024. This award is not designated with a set-aside requirement, indicating open competition....